vs
Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $31.5M, roughly 1.2× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -161.8%, a 169.9% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 4.8%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CHCT vs IBRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.5M | $38.3M |
| Net Profit | $2.5M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | — | -169.0% |
| Net Margin | 8.1% | -161.8% |
| Revenue YoY | 4.8% | 407.0% |
| Net Profit YoY | 60.2% | -4.7% |
| EPS (diluted) | — | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $31.5M | — | ||
| Q4 25 | $30.9M | $38.3M | ||
| Q3 25 | $31.1M | $32.1M | ||
| Q2 25 | $29.1M | $26.4M | ||
| Q1 25 | $30.1M | $16.5M | ||
| Q4 24 | $29.3M | $7.6M | ||
| Q3 24 | $29.6M | $6.1M | ||
| Q2 24 | $27.5M | — |
| Q1 26 | $2.5M | — | ||
| Q4 25 | $14.4M | $-61.9M | ||
| Q3 25 | $1.6M | $-67.3M | ||
| Q2 25 | $-12.6M | $-92.6M | ||
| Q1 25 | $1.6M | $-129.6M | ||
| Q4 24 | $1.8M | $-59.2M | ||
| Q3 24 | $1.7M | $-85.7M | ||
| Q2 24 | $-10.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | -169.0% | ||
| Q3 25 | — | -173.5% | ||
| Q2 25 | — | -269.8% | ||
| Q1 25 | — | -390.1% | ||
| Q4 24 | — | -919.0% | ||
| Q3 24 | — | -1314.3% | ||
| Q2 24 | — | — |
| Q1 26 | 8.1% | — | ||
| Q4 25 | 46.6% | -161.8% | ||
| Q3 25 | 5.3% | -209.8% | ||
| Q2 25 | -43.2% | -350.3% | ||
| Q1 25 | 5.3% | -784.9% | ||
| Q4 24 | 6.3% | -783.4% | ||
| Q3 24 | 5.9% | -1404.0% | ||
| Q2 24 | -37.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | $0.52 | $-0.06 | ||
| Q3 25 | $0.03 | $-0.07 | ||
| Q2 25 | $-0.50 | $-0.10 | ||
| Q1 25 | $0.03 | $-0.15 | ||
| Q4 24 | $0.04 | $-0.08 | ||
| Q3 24 | $0.04 | $-0.14 | ||
| Q2 24 | $-0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $421.3M | $-500.5M |
| Total Assets | $1.0B | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.6M | — | ||
| Q4 25 | $3.3M | $242.8M | ||
| Q3 25 | $3.4M | $257.8M | ||
| Q2 25 | $4.9M | $153.7M | ||
| Q1 25 | $2.3M | $61.6M | ||
| Q4 24 | $4.4M | $149.8M | ||
| Q3 24 | $2.8M | $130.4M | ||
| Q2 24 | $734.0K | — |
| Q1 26 | — | — | ||
| Q4 25 | $532.2M | — | ||
| Q3 25 | $530.1M | — | ||
| Q2 25 | $500.1M | — | ||
| Q1 25 | $496.0M | — | ||
| Q4 24 | $486.0M | — | ||
| Q3 24 | $473.7M | — | ||
| Q2 24 | $457.6M | — |
| Q1 26 | $421.3M | — | ||
| Q4 25 | $429.4M | $-500.5M | ||
| Q3 25 | $426.8M | $-524.3M | ||
| Q2 25 | $437.8M | $-570.7M | ||
| Q1 25 | $461.3M | $-591.4M | ||
| Q4 24 | $476.0M | $-489.1M | ||
| Q3 24 | $477.2M | $-745.1M | ||
| Q2 24 | $497.8M | — |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $990.8M | $501.9M | ||
| Q3 25 | $987.3M | $519.0M | ||
| Q2 25 | $966.3M | $402.1M | ||
| Q1 25 | $985.1M | $303.8M | ||
| Q4 24 | $992.6M | $382.9M | ||
| Q3 24 | $981.8M | $364.6M | ||
| Q2 24 | $983.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.92× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-70.4M |
| Free Cash FlowOCF − Capex | — | $-71.3M |
| FCF MarginFCF / Revenue | — | -186.2% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $56.4M | $-70.4M | ||
| Q3 25 | $12.7M | $-68.9M | ||
| Q2 25 | $13.8M | $-79.7M | ||
| Q1 25 | $14.4M | $-85.9M | ||
| Q4 24 | $58.9M | $-85.1M | ||
| Q3 24 | $13.8M | $-98.8M | ||
| Q2 24 | $16.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $35.9M | $-71.3M | ||
| Q3 25 | $7.6M | $-69.6M | ||
| Q2 25 | $9.6M | $-80.8M | ||
| Q1 25 | $9.7M | $-87.0M | ||
| Q4 24 | $34.2M | $-87.3M | ||
| Q3 24 | $6.7M | $-101.6M | ||
| Q2 24 | $9.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 116.0% | -186.2% | ||
| Q3 25 | 24.6% | -217.2% | ||
| Q2 25 | 32.9% | -305.9% | ||
| Q1 25 | 32.3% | -526.9% | ||
| Q4 24 | 116.9% | -1155.4% | ||
| Q3 24 | 22.5% | -1663.2% | ||
| Q2 24 | 34.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 66.3% | 2.4% | ||
| Q3 25 | 16.3% | 2.3% | ||
| Q2 25 | 14.5% | 4.1% | ||
| Q1 25 | 15.6% | 6.8% | ||
| Q4 24 | 84.1% | 28.0% | ||
| Q3 24 | 24.2% | 45.7% | ||
| Q2 24 | 26.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.91× | — | ||
| Q3 25 | 7.76× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.06× | — | ||
| Q4 24 | 32.14× | — | ||
| Q3 24 | 7.92× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
